- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 1 is the deadline for discounted registration for the 4th International Dendrimer Symposium May 18 to 21 at Central Michigan University.
IDS-4 is being held for the first time in the United States, said Brent Case, technology business development coordinator for CMU Research Corp., which is hosting the event with CMU.
“This is a premiere event in the field of dendrimer nanotechnology,” said Case. “It is drawing the top scientists, industry leaders and others who want to know the latest developments in this emerging field.”
Dendrimers are complex nanostructures that have a wide variety of applications in electronics, apparel design, the military, pharmaceuticals, and DNA compounds and activity. Previous conventions were held in Frankfurt, Germany; Tokyo, Japan; and Berlin, Germany.
“The central Michigan area and CMU are being recognized as top locations for this type of research and for business development,” said Case. “The area is easily accessible, and the costs of doing business are lower than in more expensive metropolitan areas. Businesses see this as the merger of efficiency with the best technology, innovation and competition.”
IDS-4 will feature more than 80 internationally recognized speakers from more than a dozen countries. Topics will range from the growth and structure of dendritic architectures to its properties and applications. Nearly 100 poster displays by an international array of students and 20 exhibit booths will be displayed at the CMU Bovee University Center throughout the conference.
Symposium sponsors include Army Research Laboratories, Starpharma, Dendritic NanoTechnologies Inc., CMU, the CMU Research Corp., MichBio, Michigan Economic Development Corp. and Small Times Media.
CMU is a prime location for IDS-4 because of a planned $4.5 million laboratory. The state-of-the-art facility will contain several wet-laboratories and a bio-level 2 lab to meet the needs of the dendrimer center’s industry partners, including Dendritic NanoTechnologies and MultiGEN, two research-based companies that have partnered with the university. The facility is funded by a $2.15 million dollar grant from the U.S. Department of Commerce Economic Development Administration, matching support from CMU and part of a $750,000 grant from the Michigan Economic Development Corp.
A recent agreement between Dendritic NanoTechnologies, The Dow Chemical Co. and Starpharma of Melbourne, Australia, will provide access to the world’s broadest patent portfolio in the field of dendrimers that will support commercialization of nanotechnology.
Register for IDS-4 online at www.ids4.org
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016